Search results
Daphne Koller (Hebrew: דפנה קולר; born August 27, 1968) is an Israeli-American computer scientist. She was a professor in the department of computer science at Stanford University and a MacArthur Foundation fellowship recipient. She is one of the founders of Coursera, an online education platform.
- August 27, 1968 (age 55), Israel
Professor Daphne Koller Contact Information: home | biography | research | papers | my group courses | professional activities | FAQ | personal
Daphne Koller is CEO and founder of insitro, a machine learning-driven drug discovery and development company transforming the way drugs are discovered and delivered to patients. She was the co-founder, co-CEO, and president of online education platform Coursera, the largest platform for massive open online courses (MOOCs), which has reached ...
Support vector machine active learning with applications to text classification. S Tong, D Koller. Journal of machine learning research 2 (Nov), 45-66. , 2001. 3788. 2001. A gene-coexpression network for global discovery of conserved genetic modules. JM Stuart, E Segal, D Koller, SK Kim. science 302 (5643), 249-255.
Daphne Koller is a professor of computer science and pathology at Stanford University. She has received many honors, including the MacArthur Foundation Fellowship, the ACM/Infosys Award, and the National Academy of Engineering membership.
Daphne Koller is a Stanford University professor and the Rajeev Motwani Professor in the School of Engineering. She is a leading expert in machine learning and probabilistic methods for complex domains, such as computational biology, medicine, and sensor data. She has published over 200 refereed publications and given keynote talks at various conferences and venues.
People also ask
Who is Daphne Koller?
What is Daphne Koller's net worth?
Who is Daphne Koller married to?
Nov 3, 2020 · Daphne Koller is a veteran of the age of artificial intelligence and a leader in the use of machine learning to explore the causes and potential treatments for some serious diseases. She founded a company, insitro, that uses machine learning to help drug developers find new candidates. She shares her insights on the challenges and rewards of this field and the lessons she’s learned along the way.
Related searches
